title: [Analysis on epidemiological characteristics of measles before and after measles vaccine supplement immunization activities in Changzhou municipal in 2007].
abstract: OBJECTIVE
  To analyze the epidemiological characteristics of measles before and after measles attenuated live vaccine (MV) supplementary immunization activities (SIAs) in Changzhou municipal in 2007-2008 and approach measures of measles elimination.
  
  
  METHODS
  Analyze measles epidemiology and control measures with descriptive epidemiology.
  
  
  RESULTS
  After SIAs in Nov.2007, the reported measles incidence was 24.13/100000, and increased by 91.60% in 2008 than in 2007, except Jintan and Liyang town, the others were higher in 2008 than in 2007. The reported measles incidence of 5-9 years old was lower in 2008 than in 2007. However, the reported measles incidence of other age groups was higher. One incidence peak reached 216.92/100000 was found in < 1 year old group and another peak appeared at aged 20-30 years old group. The proportions of measles cases of 8 months-14 years old in 2007 and 2008 were 53.47% and 54.38%. 7.37% and 4.18% of them received MV respectively. The reported cases in 2008 increased and 68.05% of them were floating population.
  
  
  CONCLUSIONS
  Low coverage of MVwas the main cause of high measles incidence. It indicated that a timely and strengthened routine vaccination, a high quality SIA, and well organized floating population management and surveillance are essential strategies to eliminate measles.
authors.affiliation: Public Health School of Peking Union Medical College, Beijing 102200, China.
authors.forename: Qian
authors.initials: Q
authors.lastname: Zhang
authors.forename: Jian-Tao
authors.initials: JT
authors.lastname: Zhang
authors.forename: Chen
authors.initials: C
authors.lastname: Bian
mesh_terms: D000293:Adolescent; D000328:Adult; D017677:Age Distribution; D002648:Child; D002675:Child, Preschool; D002681:China / Q000453:epidemiology; D005260:Female; D006801:Humans; D007114:Immunization / Q000379:methods* / Q000706:statistics & numerical data*; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D008457:Measles / Q000453:epidemiology* / Q000517:prevention & control*; D008458:Measles Vaccine / Q000276:immunology*; D014505:Urban Population / Q000706:statistics & numerical data*; D014613:Vaccines, Attenuated / Q000276:immunology; D055815:Young Adult
chemical_list: D008458:Measles Vaccine; D014613:Vaccines, Attenuated